| Literature DB >> 30134906 |
Sipeng Shen1,2,3, Ruyang Zhang1,2,3, Jinming Zhang2, Yongyue Wei1,3, Yichen Guo2, Li Su2,3, Feng Chen1,3, David C Christiani4,5,6.
Abstract
BACKGROUND: Increasing evidence suggests that welding fume exposure is associated with systemic inflammation. Although celluar metabolites may be associated with inflammation, there is limited information on metabolomic changes during welding fume exposure. Such changes may play an important role in the occurrence, development, and prevention of metal-associated diseases. We aim to investigate human metabolomics changes pre- and post-welding fume exposure.Entities:
Keywords: Boilermaker; Environmental exposures; Inflammation; Metabolomics; Occupational health; Welding fume exposure
Mesh:
Substances:
Year: 2018 PMID: 30134906 PMCID: PMC6106842 DOI: 10.1186/s12940-018-0412-z
Source DB: PubMed Journal: Environ Health ISSN: 1476-069X Impact factor: 5.984
Demographic characteristics of the study population
| Characteristic | Mean ± SD or N |
|---|---|
| Sample size | 52a |
| Sample collecting time | |
| Morning and afternoon | 29 |
| Afternoon and evening | 23 |
| Age (years) | 40.91 ± 12.22 |
| Welding time (hours/month) | 33.06 ± 25.51 |
| BMI (kg/m2) | 28.43 ± 5.41 |
| Weight (kg) | 89.53 ± 17.89 |
| Height (m) | 1.77 ± 0.08 |
| Gender | |
| Male | 50 |
| Female | 1 |
| Race | |
| Caucasian | 43 |
| African American | 4 |
| Asian | 2 |
| Hispanic | 2 |
| Current smoker | |
| Yes | 21 |
| No | 30 |
| Medical history | |
| Diabetes | 4 |
| High blood pressure | 5 |
| Irregular heart arrhythmia | 2 |
| High cholesterol hyperlipidemia | 7 |
aBaseline information of one sample was missing
Fig. 1Heatmap of 113 significantly altered metabolites, hierarchically clustered for compounds (row) and samples (column). Batch information, smoking status, and exposure group are labeled at the top
Significant superpathways and subpathways in pathway enrichment analysis
| Pathway | Number | Different | Percentage (%) | Upa | Downa | P | FDR- |
|---|---|---|---|---|---|---|---|
| Superpathway | |||||||
| Lipid | 321 | 61 | 19 | 37 | 24 | 2.18E-56 | 1.75E-55 |
| Amino acid | 158 | 22 | 13.92 | 19 | 3 | 7.37E-19 | 2.95E-18 |
| Xenobiotics | 97 | 10 | 8.77 | 10 | 0 | 9.41E-09 | 2.51E-08 |
| Carbohydrate | 21 | 8 | 38.09 | 7 | 1 | 4.04E-07 | 8.08E-07 |
| Cofactors and vitamins | 20 | 5 | 25 | 0 | 5 | 1.07E-04 | 1.71E-04 |
| Nucleotide | 30 | 4 | 13.33 | 2 | 2 | 6.76E-04 | 9.01E-04 |
| Energy | 9 | 2 | 22.22 | 2 | 0 | 2.64E-02 | 3.02E-02 |
| Subpathway | |||||||
| Lysolipid | 24 | 10 | 41.67 | 10 | 0 | 1.91E-07 | 7.84E-06 |
| Phospholipid Metabolism | 33 | 8 | 24.24 | 8 | 0 | 4.47E-06 | 9.17E-05 |
| Fatty Acid Metabolism (Acyl Carnitine) | 23 | 7 | 30.43 | 0 | 7 | 2.14E-05 | 1.75E-04 |
| Food Component/Plant | 31 | 7 | 22.58 | 7 | 0 | 2.14E-05 | 1.75E-04 |
| Phenylalanine and Tyrosine Metabolism | 29 | 7 | 24.14 | 6 | 1 | 2.14E-05 | 1.75E-04 |
| Polyunsaturated Fatty Acid (n3 and n6) | 13 | 6 | 46.15 | 1 | 5 | 1.02E-04 | 6.94E-04 |
| Diacylglycerol | 19 | 5 | 26.32 | 5 | 0 | 4.79E-04 | 2.80E-03 |
| Fatty Acid, Monohydroxy | 14 | 4 | 28.57 | 2 | 2 | 2.24E-03 | 8.35E-03 |
| Hemoglobin and Porphyrin Metabolism | 5 | 4 | 80.00 | 0 | 4 | 2.24E-03 | 8.35E-03 |
| Leucine, Isoleucine and Valine Metabolism | 24 | 4 | 16.67 | 3 | 1 | 2.24E-03 | 8.35E-03 |
| Steroid | 36 | 4 | 11.11 | 0 | 4 | 2.24E-03 | 8.35E-03 |
| Endocannabinoid | 5 | 3 | 60.00 | 0 | 3 | 1.04E-02 | 3.05E-02 |
| Fructose, Mannose and Galactose Metabolism | 4 | 3 | 75.00 | 2 | 1 | 1.04E-02 | 3.05E-02 |
| Pentose Metabolism | 6 | 3 | 50.00 | 3 | 0 | 1.04E-02 | 3.05E-02 |
aUp indicates higher level in the post-exposure group; down indicates lower level in the post-exposure group
Fig. 2Pre- and post-welding fume exposure levels of (a) the glucocorticoid class of cortisol, cortisone, and corticosterone; (b) acylcarnitine species; and (c) DiHOME species 9,10-DiHOME and 12,13-DiHOME. Data are expressed as mean ± standard error of mean (SEM). **FDR q-value < 0.001
Fig. 3a Pre- and post-welding fume exposure levels of 3-HPMA. Data are expressed as mean ± SEM. b Interaction plot of 3-HPMA levels and smoking status for pre- and post-welding fume exposure groups. Psmoking indicates t-test P-value of 3-HPMA within the smoking subgroup, while Pnon-smoking indicates P-value within the non-smoking subgroup. Two-way analysis of variance was used based on log-transformed data. Pinteraction indicates P-value of interaction effects
Fig. 4MetaboAnalyst metabolite set enrichment analysis of disease-associated metabolite sets in blood. Figure shows –log10(p) values for the top 20 significant pathways